1-15 of 15
Thérèse Aurran, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maintenance of Long-Term Undetectable Minimal Residual Disease after Combination of Ibrutinib with Abbreviated Chemotherapy in the Icll-07 Filo Trial

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, MD, Bruno Villemagne, MD, Gilles A. Salles, MD PhD, Olivier Tournilhac, Alain Jacques Delmer, MD PhD, Christelle Portois, Brigitte Pegourie, MD, Veronique Leblond, MD PhD, Cecile Tomowiak, MD, Sophie de Guibert, MD, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, MD PhD, Loic Ysebaert, MD PhD, Caroline Dartigeas, MD, Margot Truchan, Jean Pierre Vilque, Thérèse Aurran, MD, Florence Cymbalista, MD PhD, Stephane Lepretre, Vincent Levy, MD PhD, Florence Nguyen-Khac, MD PhD, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3038.
https://doi.org/10.1182/blood-2019-126720
Published: 2019
Journal Articles

Open Label Non-Randomized Phase II Study Exploring «Chemo-Free » Treatment Association with Idelalisib + Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis of the Induction Phase

Cecile Tomowiak, MD, Kristell Desseaux, Stéphanie Poulain, MD PhD, Charles Herbaux, MD, Aurore Perrot, MD PhD, Beatrice Mahe, MD, Pierre Morel, MD, Olivier Tournilhac, Stephane Lepretre, MD, Thérèse Aurran, MD, Bruno Villemagne, MD, Olivier Casasnovas, MD, Delphine Nollet, Brigitte Dreyfus, MD, Sylvie Chevret, MD PhD, Veronique Leblond, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 346.
https://doi.org/10.1182/blood-2019-122826
Published: 2019
Journal Articles

p53 Functional Assessment and Correlation with 17p Deletion and/or TP53 Mutation Status: Final Report of the ICLL001 Bomp Trial

Magali Le Garff-Tavernier, Claire Quiney, Lauren Veronese, MD PhD, Florence Nguyen-Khac, MD PhD, Pauline Robbe, MSc, PhD, Patricia Combes, Marie-Sarah Dilhuydy, MD, Pierre Feugier, Beatrice Mahe, MD, Laurence Sanhes, MD, Alain Jacques Delmer, MD, Loic Ysebaert, MD PhD, Malgorzata Truchan-Graczyk, Brigitte Dreyfus, MD, Choquet Sylvain, MD, Thérèse Aurran, MD, Emmanuelle Ferrant, MD, Caroline Dartigeas, MD, Stéphane Leprêtre, MD, Gian Matteo Pica, MD, Frederic Davi, MD PhD, Bruno Pereira, Roselyne Delepine, Anna Schuh, MD PhD, Romain Guieze, MD, Jacques-Olivier Bay, MD PhD, Véronique Leblond, MD PhD, Helene Merle-Beral, MD PhD, Sophie de Guibert, MD, Olivier Tournilhac, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3127.
https://doi.org/10.1182/blood-2018-99-116722
Published: 2018
Journal Articles

Outcome of Patients Receiving Venetoclax for Chronic Lymphocytic Leukemia (CLL) in Real-Life Clinical Practice: Results of the French ATU Program on Behalf of the Filo Group

Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, MD, Sandy Amorim, MD, Florence Cymbalista, MD PhD, Charles Herbaux, MD, Sophie de Guibert, MD, Damien Roos-Weil, MD, Benedicte Hivert, MD, Thérèse Aurran, MD, Jehan Dupuis, MD, Anaise Blouet, MD, Emmanuelle Tchernonog, MD, Kamel Laribi, MD, Natalia Dmytruk, MD, Pierre Morel, Anne-Sophie Michallet, MD PhD, Caroline Dartigeas, MD, Laure Farnault, MD, Anne Lavaud, MD, Isabelle Plantier, MD, Jacques-Olivier Bay, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Pierre Feugier, Loic Ysebaert, MD PhD, Romain Guieze, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5549.
https://doi.org/10.1182/blood-2018-99-118622
Published: 2018
Journal Articles

Kinase Inhibitors (ibrutinib or idelalisib) in the Management of Chronic Lymphocytic Leukemia-Associated Autoimmune Cytopenia: A Retrospective Study of the French Innovative Leukemia Organization (FILO)

Sophie Godet, MD, Anne Quinquenel, Caroline Dartigeas, MD, Loic Ysebaert, MD PhD, Jehan Dupuis, MD, Haykanush Ohanyan, Aude Collignon, Laurent Gilardin, MD MSc, Stéphane Leprêtre, MD, Marie-Sarah Dilhuydy, MD, Marguerite Vignon, MD, Sophie de Guibert, MD, Natalia Dmytruk, MD, Eric Durot, MD, David Ghez, MD PhD, Damien Roos-Weil, MD, Elise Toussaint, MD, Fatiha Merabet, MD, Vincent Levy, MD PhD, Alain Jacques Delmer, MD, Thérèse Aurran, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3152.
https://doi.org/10.1182/blood-2018-99-112654
Published: 2018
Journal Articles

High Rate of Complete Response (CR) with Undetectable Bone Marrow Minimal Residual Disease (MRD) after Chemo-Sparing and MRD-Driven Strategy for Untreated Fit CLL Patients: Final Results of the Icll 07 Filo Trial

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, MD, Bruno Villemagne, Gilles Andre Salles, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Christelle Portois, Brigitte Pegourie, MD, Véronique Leblond, MD PhD, Cecile Tomowiak, MD, Sophie de Guibert, MD, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, MD PhD, Caroline Dartigeas, Margot Truchan, Thérèse Aurran, MD, Florence Cymbalista, MD, Stéphane Leprêtre, MD, Vincent Levy, MD PhD, Florence Nguyen-Khac, MD PhD, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier
Journal: Blood
Blood (2018) 132 (Supplement 1): 1858.
https://doi.org/10.1182/blood-2018-99-111977
Published: 2018
Journal Articles

Phase II, Multicenter Trial, Exploring "Chemo-Sparing" Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, Bruno Villemagne, Gilles Andre Salles, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Christelle Portois, Brigitte Pegourie, MD, Veronique Leblond, Cecile Tomowiak, MD, Sophie de Guibert, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, MD PhD, Caroline Dartigeas, Margot Truchan, Thérèse Aurran, MD, Florence Cymbalista, MD, Stéphane Leprêtre, MD, Vincent Levy, MD PhD, Florence Nguyen Khac, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 497.
https://doi.org/10.1182/blood.V130.Suppl_1.497.497
Published: 2017
Journal Articles

A Retrospective Analysis of 450 TP53 Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group

Fanny Baran-Marszak, MD PhD, Valerie Vidal, Myriam Hormi, Virginie Eclache, Lauren Veronese, MD PhD, Olivier Tournilhac, MD PhD, Frederic Davi, Florence Nguyen-Khac, MD PhD, Veronique Leblond, Eric Delabesse, MD PhD, Loic Ysebaert, MD PhD, Audrey Bidet, PharmD, Marie-Sarah Dilhuydy, MD, Stephanie Poulain, MD PhD, Charles Herbaux, Marie-Helene Estienne, PharmD, Caroline Dartigeas, Cedric Pastoret, MD, Sophie de Guibert, Stephane Giraudier, MD PhD, Jehan Dupuis, MD, Pascale Cornillet-Lefebvre, Anne Quinquenel, Sophy Laibe, Thérèse Aurran, MD, Dina Naguib, MD MASTERS, Xavier Troussard, MD, Pierre Sujobert, MD PhD, Anne-Sophie Michallet, MD PhD, Catherine Thieblemont, MD PhD, Remi Letestu, Gregory Lazarian, PharmD, Vincent Levy, MD PhD, Thierry Soussi, Sophie Raynaud, MD PhD, Florence Cymbalista, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1722.
https://doi.org/10.1182/blood.V130.Suppl_1.1722.1722
Published: 2017
Journal Articles

Interim Analysis of Lenalidomide Consolidation on Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)

David Gottlieb, MBBS MDFRACP FRCPA, Thérèse Aurran, MD, Constantine S. Tam, MD, Mary Sartor, PhD, Rémi Letestu, MD PhD, Dennis Carney, Gavin Cull, MBBS DM FRACP FRCPA, Vincent Levy, MD PhD, Veronique Leblond, MD PhD, Marie Christine Bene, Andrew Budniak, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Florence Cymbalista, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2053.
https://doi.org/10.1182/blood.V128.22.2053.2053
Published: 2016
Journal Articles

Bing Neel Syndrome: The French Experience

Laurence Simon, Xavier Leleu, MD PhD, Jehan Dupuis, MD, Therese Aurran, MD, Lauris Gastaud, MD, Carole Soussain, MD, Beatrice Mahe, MD, Stephane Lepretre, MD, Borhane Slama, Guillaume Cartron, MD, Charlotte Bonnet, Olivier Gisserot, Camille Payet, Veronique Leblond, MD PhD, Luc Fornecker, MD
Journal: Blood
Blood (2014) 124 (21): 3068.
https://doi.org/10.1182/blood.V124.21.3068.3068
Published: 2014
Journal Articles

Results of a Phase II Randomizing Intensified Rituximab Pre-Phase Followed By Standard FCR Vs Standard FCR in Previously Untreated Patients with Active B-Chronic Lymphocytic Leukemia (B-CLL). CLL2010FMP (for fit medically patients): A Study of the french Cooperative Group on CLL and WM (FCGCLL/MW) and the “Groupe Ouest-Est d’Etudes Des Leucémies Aigües Et Autres Maladies Du sang” (GOELAMS)

Stephane Lepretre, MD, Rémy Letestu, MD PhD, Caroline Dartigeas, MD, Hervé Maisonneuve, MD, Therese Aurran, MD, Pierre Feugier, MD PhD, Sophie de Guibert, MD, Anne Bannos, MD, Bernadette Corront, MD, Veronique Leblond, MD PhD, Alain Delmer, MD PhD, Anne Laure Gagez, PhD, Valérie Rouillé, Sandrine Vaudaux, Florence Cymbalista, MD, Guillaume Cartron, MD, Emmanuelle Ferrant, MD, Beatrice Mahe, MD, Romain Guièze, MD
Journal: Blood
Blood (2014) 124 (21): 3329.
https://doi.org/10.1182/blood.V124.21.3329.3329
Published: 2014
Journal Articles

Updated Follow-Up In The CLL2007FMP Trial Supports The Non Superiority Of The Association Fludarabine-Cyclophosphamide (FC) Plus Campath Compared To FC Plus Rituximab and Points Out The Importance Of Minimal Residual Disease, By 6-Color Flow Cytometry Technique, On Progression Free Survival

Pierre Feugier, MD, PhD, Remi Letestu, MD, Sylvie Chevret, Thérèse Aurran, MD, Beatrice Mahe, Bruno Cazin, MD, Olivier Tournilhac, MD, PhD, Hervé Maisonneuve, Olivier Casasnovas, MD, Alain Delmer, MD, Véronique Leblond, MD, PhD, Bruno Royer, MD, Brigitte Corront, MD, Roselyne Delepine, Sandrine Vaudaux, Eric Van Den Neste, MD, PhD, Marie C Béné, PharmSciD, PhD, Florence Cymbalista, MD, PhD, Stéphane Leprêtre, MD
Journal: Blood
Blood (2013) 122 (21): 2870.
https://doi.org/10.1182/blood.V122.21.2870.2870
Published: 2013
Journal Articles

Autologous Stem Cell Transplantation (auto-SCT) in Elderly Patients with Multiple Myeloma (MM): Age per se Does Not Affect Outcome.

Jean El-Cheikh, MD, Elias Kfoury, MD, Christian Chabannon, MD, PhD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD, Diane Coso, MD, Jean-Marc Schiano de Collela, MD, Vadim Ivanov, MD, Therese Aurran, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 947.
https://doi.org/10.1182/blood.V110.11.947.947
Published: 2007
Journal Articles

Good Safety and Tolerance Profiles of Long Term Treatment of Advanced Multiple Myeloma (MM) with Bortezomib.

Jean El-Cheikh, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD, Diane Coso, MD, Jean-Marc Schiano de Collela, MD, Therese Aurran, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4811.
https://doi.org/10.1182/blood.V110.11.4811.4811
Published: 2007
Journal Articles

Feasability of High Dose Melphalan and Peripheral Blood Stem Cell Support(IPC-LAM 2000) for Patients over 60 Years with Acute Myeloid Leukemia(AML) in First Remission(CR1):Final Analysis.

Anne-Marie Stoppa, MD, Norbert Vey, MD, Reda Bouabdallah, MD, Catherine Faucher, MD, Diane Coso, MD, Aude Charbonnier, MD, PhD, Jean Marc Schianno, MD, Therese Aurran, MD, Christian Chabannon, MD, PhD, Danielle Sainty, MD, Marina Lafage, MD, PhD, Didier Blaise, MD, Jean Albert Gastaud, MD, Dominique Maraninchi, MD
Journal: Blood
Blood (2005) 106 (11): 2922.
https://doi.org/10.1182/blood.V106.11.2922.2922
Published: 2005